The Two-Minute Step Test in Heart Failure: A Practical Step Forward, Pending Validation

1/2 https://e-heartfailure.org Exercise intolerance is among the most defining and prognostically important features of chronic heart failure (HF). 1) Reduced functional capacity is not merely a marker of symptom burden; it predicts hospitalization and death and reflects the multisystem character of the syndrome, encompassing impaired cardiac reserve alongside pulmonary, vascular, and skeletal muscle abnormalities.Measuring it accurately and repeatably is therefore central to risk stratification and to monitoring the response to cardiac rehabilitation.Cardiopulmonary exercise testing (CPET) with peak oxygen uptake remains the reference standard, yet its equipment, cost, and space requirements place it beyond reach in most routine settings. 2) For this reason, the six-minute walk test (6MWT) 3) has become the most widely used field measure of functional capacity in HF, with well-established prognostic value in this population. 4) The 6MWT nonetheless has an important practical constraint: it requires a long, unobstructed corridor that many outpatient clinics, community programs, and home-based services do not have.This limitation has renewed interest in step-based tests requiring minimal space and equipment.The two-minute step test (2MST), originally developed for community-dwelling older adults, 5) is among the most extensively studied of these.Its reliability and construct validity have been reported across diverse populations, 6) yet its interpretation in HF remains constrained by the absence of a disease-specific threshold, 7) a gap that the present study sets out to address.In this issue of the International Journal of Heart Failure, the authors 8) report a cross-sectional study of 60 clinically stable patients with chronic HF and reduced ejection fraction, each of whom completed the 2MST, the 6MWT, and quadriceps strength testing in randomized order.Using receiver operating characteristic analysis against a six-minute walk distance of 350 m, they identified a cut-off of 94 steps that discriminated reduced functional capacity with good accuracy (area under the curve, 0.82) and high sensitivity (83%).After adjustment for age, sex, and New York Heart Association (NYHA) class, patients meeting the threshold walked approximately 34 m farther, a difference exceeding commonly reported minimal clinically important differences, and reported lower post-exercise leg fatigue.Cardiorespiratory and perceptual responses were otherwise comparable to the 6MWT, differing chiefly in greater localized leg fatigue.These findings are encouraging but warrant the caution the authors themselves advocate.This is a single-center study of modest size in a relatively young, clinically stable cohort largely in NYHA class I-II.How the 94-step threshold performs in older patients, in the underrepresented women of the sample, or in more advanced disease remains unknown.